ESR1 and breast cancer: Clinically, BC is classified into three basic therapeutic groups as follows: estrogen-receptor (ER) positive, ERBB2 (also called HER2)-positive, and triple-negative, lacking expression of ER, progesterone-receptor (PgR) and ERBB2 [43].